Serious Toxicities Associated With Stereotactic Body Radiotherapy (SBRT) And Strategies To Reduce The Risks
WebcastFaculty
OVERVIEW
Serious Toxicities Associated With Stereotactic Body Radiotherapy (SBRT) And Strategies To Reduce The Risks is organized by American Society for Radiation Oncology (ASTRO) and will be held from Feb 08, 2017 - Feb 07, 2020.
The target audience for this medical event is radiation oncologists, physicists, nurses, radiation therapists, dosimetrists, radiation biologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credit.
Couse Description :
In the recent years, there has been a sharp increase of interest in the use of SBRT for the treatment of various primary and metastatic tumors of various organ sites. While promising results have been achieved in terms of tumor control and survival, serious toxicities have also been observed in various organs-at-risk. This session will provide a most up-to-date site by site account of serious complications from SBRT (what can go wrong) and strategies and maneuvers to minimize the risks of those complications (how to prevent them from happening). The data will be updated up to 1-2 weeks before the meeting. All the speakers have more than 10 years of experience in SBRT practice and research at high volume centers and have published extensively in the field of SBRT.
Learning Objectives :
• Describe the reported toxicities associated with SBRT for various organ sites and the factors predictive of serious toxicities from SBRT.
• Describe potential ways to reduce the risks of serious complications from SBRT.
• Determine most commonly used normal tissue constraints for SBRT for various body sites.
Additional details will be posted as soon as they are available.
The target audience for this medical event is radiation oncologists, physicists, nurses, radiation therapists, dosimetrists, radiation biologists and radiation oncology residents. This CME Conference has been approved for a maximum of 1.50 AMA PRA Category 1 Credit.
Couse Description :
In the recent years, there has been a sharp increase of interest in the use of SBRT for the treatment of various primary and metastatic tumors of various organ sites. While promising results have been achieved in terms of tumor control and survival, serious toxicities have also been observed in various organs-at-risk. This session will provide a most up-to-date site by site account of serious complications from SBRT (what can go wrong) and strategies and maneuvers to minimize the risks of those complications (how to prevent them from happening). The data will be updated up to 1-2 weeks before the meeting. All the speakers have more than 10 years of experience in SBRT practice and research at high volume centers and have published extensively in the field of SBRT.
Learning Objectives :
• Describe the reported toxicities associated with SBRT for various organ sites and the factors predictive of serious toxicities from SBRT.
• Describe potential ways to reduce the risks of serious complications from SBRT.
• Determine most commonly used normal tissue constraints for SBRT for various body sites.
Additional details will be posted as soon as they are available.
SPECIALITIES
OncologyRadiation Oncology
Quick Links